About SciVac Therapeutics
SciVac Therapeutics was founded in 2005 in Rehovot, Israel, as a clinical-stage biotechnology company specializing in vaccines for viral infections. A hepatitis B vaccine mimicking all three viral surface antigens was developed, offering rapid protection and lower dosing compared to alternatives. Approval was granted in Israel and 14 other countries. In 2016, merger with VBI Vaccines occurred, with the Israel unit now operating as a contract development organization.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
VBI Vaccines
(Oct 26, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SciVac Therapeutics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(31 Aug 2010)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Post-IPO - SciVac Therapeutics | Valuation |
investors |
|
| Oct, 2014 | Amount | Post-IPO - SciVac Therapeutics | Valuation |
investors |
|
| Aug, 2010 | Amount | Post-IPO - SciVac Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SciVac Therapeutics
SciVac Therapeutics has secured backing from 1 investor. Prominent investors backing the company include VBI Vaccines. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SciVac Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SciVac Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scivac Therapeutics Comparisons
Competitors of SciVac Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SciVac Therapeutics
When was SciVac Therapeutics founded?
SciVac Therapeutics was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Where is SciVac Therapeutics located?
SciVac Therapeutics is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
What does SciVac Therapeutics do?
SciVac Therapeutics was founded in 2005 in Rehovot, Israel, as a clinical-stage biotechnology company specializing in vaccines for viral infections. A hepatitis B vaccine mimicking all three viral surface antigens was developed, offering rapid protection and lower dosing compared to alternatives. Approval was granted in Israel and 14 other countries. In 2016, merger with VBI Vaccines occurred, with the Israel unit now operating as a contract development organization.
Who are SciVac Therapeutics's investors?
SciVac Therapeutics has 1 investor. Key investors include VBI Vaccines.